Earn CME: https://naccme.com/program/7330
In this presentation from the ‘CLL in the Era of Targeted Therapy’ symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Richard R. Furman utilizes a case presentation to examine personalized management strategies for relapsed/refractory, high risk patients with CLL.
© 2019 Imedex, an HMP Company